AUROPHARMA — Aurobindo Pharma Share News
0.000.00%
Last trade - 00:00- IN₹904.32bn
- IN₹877.78bn
- IN₹336.53bn
Brief: Aurobindo Pharma Clarifies Report Trump Shoots Letters To Global Drug Majors
Brief: Aurobindo Pharma To Buy 100% Interest In Lannett Seller Holdco
ViiV expands licence to allow generic HIV treatment production for low-income countries
Indian pharma stocks drop as Macquarie flags concerns around increased competition in US generics
Indian pharma stocks drop as Macquarie flags concerns around increased competition in US generics
Brief: Aurobindo Pharma Unit Pharmacin B.V. Merged With Its Holding Co
Brief: Aurobindo Pharma Unit Gets Marketing Approval For Trastuzumab Biosimilar Dazublys From European Commission
India's Aurobindo Pharma rises after unit resumes Kakinada facility output
Lilly to launch Mounjaro pen in India as Novo rivalry heats up in mega market
Brief: Aurobindo Pharma Says Curateq Biologics Receives Approval For Biosimilar Dyrupeg
US appeals court confirms patent validity of Acadia's Parkinson's drug
India's Aurobindo Pharma falls on flat FY26 margins forecast
Brief: Aurobindo Pharma Q4 Consol Net Profit 9.03 Billion Rupees
Brief: Aurobindo Pharma Says First Us FDA Submission Planned In FY26
Acadia Pharma soars after favorable court ruling in patent dispute
Indian pharma stocks fall as Trump moves to cut U.S. drug prices (updated)
Indian pharma stocks drop as Trump to sign executive order to cut prices of medicines
Indian pharma stocks drop 1% after Trump signs order to boost US drug manufacturing
Indian pharma stocks drop 1% after Trump signs order to boost U.S. drug manufacturing